Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study for the Development of a Non-invasive Diagnostic Score to Differentiate Between Essential Thrombocythemia, Premyelofibrosis and Myelofibrosis

NCT03869476 is registered in ClinicalTrials.gov with University Hospital, Angers as lead sponsor.

NCT NCT03869476
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03869476 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study for the Development of a Non-invasive Diagnostic Score to Differentiate Between Essential Thrombocythemia, Premyelofibrosis and Myelofibrosis
Lead sponsor
University Hospital, Angers
Phase
Not applicable
Overall status
Completed
Start date
July 30, 2019
Completion date
January 30, 2024
Enrollment
133 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

essential thrombocythemia, myeloproliferative disorder, primary myelofibrosis, fibrotic stage, primary myelofibrosis, prefibrotic stage